Georgia Tech researchers have developed a new biomaterial called iTOL-100 that could cure Type 1 diabetes by inducing immune acceptance of curative transplanted cells without immunosuppression.

Researchers at Georgia Tech are working to understand the lymph system through a partnership with the Global Center for Medical Innovation (GCMI).